Schedule of Available-for-Sale Debt Securities Debt Securities, Available-for-Sale [Table Text Block] Award Timing Predetermined Award Timing Predetermined [Flag] Entity File Number Entity File Number Additional Paid-in Capital Additional Paid-in Capital [Member] Realized gain included in net income, net of tax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Tabular List, Table Tabular List [Table Text Block] Recently Issued Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Restricted stock units (RSUs) withheld for taxes Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Gross Unrealized Losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Measurement Basis [Axis] Measurement Basis [Axis] Basic (in dollars per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Impairments related to credit loss Debt Securities, Available-For-Sale, Impairment Loss Debt Securities, Available-For-Sale, Impairment Loss Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Liabilities Liabilities, Fair Value Disclosure [Abstract] Remodulin Remodulin [Member] Represents Remodulin, a commercial product of the entity, for treating pulmonary arterial hypertension (PAH). Schedule of Revenue, Cost of Revenue Gross Profit by Product [Table] Schedule of Revenue, Cost of Revenue Gross Profit by Product [Table] A table disclosing the revenue, cost of revenue and gross profit by commercial product. Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Common stock issued for RSUs vested (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Adjustment to Compensation, Amount Adjustment to Compensation Amount Concentration risk, percentage Concentration Risk, Percentage Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Stock options Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Cash and cash equivalents Cash and Cash Equivalents [Member] Excise tax on net share repurchase Share repurchase program, excise tax Share Repurchase Program, Excise Tax Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-Sale [Table] Insider Trading Policies and Procedures [Line Items] Total share-based compensation expense before tax Share-based compensation expense before taxes Share-Based Payment Arrangement, Expense Schedule of Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Current assets: Assets, Current [Abstract] Total liabilities and stockholders’ equity Liabilities and Equity Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Liabilities and stockholders’ equity Liabilities and Equity [Abstract] Cover [Abstract] Cover [Abstract] Cash and cash equivalents, fair value disclosure Cash and Cash Equivalents, Fair Value Disclosure Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Share-based compensation expense, net of taxes Share-Based Payment Arrangement, Expense, after Tax Exercisable at the end of the period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Total Debt Securities, Available-for-Sale, Unrealized Loss Position Concentration Risk Type [Domain] Concentration Risk Type [Domain] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Debt Debt Instrument [Line Items] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Treasury Stock Treasury Stock, Common [Member] Nebulized Tyvaso Nebulized Tyvaso [Member] Nebulized Tyvaso Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Other non-current liabilities Other Liabilities, Noncurrent Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Non-current marketable investments Debt Securities, Available-for-Sale, Excluding Accrued Interest, Noncurrent Name Measure Name Stock Options with Performance Conditions Share-Based Payment Arrangement, Option With Performance Conditions [Member] Share-Based Payment Arrangement, Option With Performance Conditions Schedule of Share-Based Compensation (Benefit) Expense Recognized Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Maturities of available-for-sale debt securities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale Document Fiscal Period Focus Document Fiscal Period Focus Goodwill and other intangible assets, net Intangible Assets, Net (Including Goodwill) Award Timing Method Award Timing Method [Text Block] Litigation Case [Domain] Litigation Case [Domain] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss Award Type [Axis] Award Type [Axis] Long-term debt Long-Term Debt Legal Entity [Axis] Legal Entity [Axis] Total assets Assets Unituxin Unituxin [Member] Represents Unituxin, a commercial product of the entity, for treating pulmonary arterial hypertension (PAH). Schedule of Restricted Stock Units Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Trading Symbol Trading Symbol Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Geographical [Domain] Geographical [Domain] Entity Address, City or Town Entity Address, City or Town Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Inventories Inventory Disclosure [Text Block] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount RSUs Restricted Stock Units (RSUs) [Member] Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Schedule of Stock Option Exercise Data Schedule of Service Share-based Compensation, Employee and Nonemployee Stock Option Exercise Data [Table Text Block] Tabular disclosure of employee and non-employee stock option exercise data. Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Assets Assets, Fair Value Disclosure [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-Sale [Line Items] Outstanding at beginning of the period (in shares) Outstanding at the end of the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Repayment of line of credit Repayments of Lines of Credit Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] 2022 Credit Agreement Credit Agreement2022 [Member] Credit Agreement2022 Level 2 Fair Value, Inputs, Level 2 [Member] Due in one to three years Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling Year One Through Year Three, Fair Value Fair value of available-for-sale debt securities maturing after first fiscal year through third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Basis of Presentation Basis of Accounting [Text Block] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Defined benefit pension plan: Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent [Abstract] Plan Name [Axis] Plan Name [Axis] PEO PEO [Member] Schedule of the Contractual Maturities Investments Classified by Contractual Maturity Date [Table Text Block] Interest income Investment Income, Interest Due within one year Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value Additional accrual Loss Contingency Accrual, Period Increase (Decrease) U.S. UNITED STATES Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] 2026 Share Repurchase Program 2026 Share Repurchase Program [Member] 2026 Share Repurchase Program Retained Earnings Retained Earnings [Member] Furniture, equipment, and vehicles Furniture Equipment And Vehicles [Member] Details pertaining to equipment used to produce goods and services. It also includes long-lived, depreciable assets, commonly used in offices and stores and for road transportation. Number of RSUs Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income Statement [Abstract] Income tax expense Income Tax Expense (Benefit) 12 months or longer Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Products and Services [Domain] Product and Service [Domain] Customer Concentration Customer Concentration Risk [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Reported under the following captions in our consolidated balance sheets: Debt Securities, Available-for-Sale [Abstract] Property, plant and equipment, gross Property, Plant and Equipment, Gross Payments to acquire long-term investments Payments to Acquire Long-Term Investments Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Total liabilities Liabilities, Fair Value Disclosure Basis of Presentation Organization, Consolidation and Presentation of Financial Statements [Abstract] Actuarial gain (loss) arising during period, net of tax Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Equity, Class of Treasury Stock [Line Items] Equity, Class of Treasury Stock [Line Items] Proceeds from the exercise of stock options Cash received Proceeds from Stock Options Exercised City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] 2019 Inducement Plan Inducement Stock Incentive Plan2019 [Member] This member represents Inducement Stock Incentive Plan, 2019. All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Deposits Advance Payment Related to Property Plant and Equipment Advance Payment Related to Property Plant and Equipment Unvested at the end of the period (in Years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Class of Treasury Stock [Table] Class of Treasury Stock [Table] Unvested at beginning of the period (in shares) Unvested at the end of the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Commitments and Contingencies Disclosure [Abstract] Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash provided by operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Fair Value Total Debt Securities, Available-for-Sale, Excluding Accrued Interest Sales of available-for-sale debt securities Proceeds from Sale of Debt Securities, Available-for-Sale Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Distributor 1 Distributor One [Member] Distributor One Revenues from external customers by geographic area Revenues from External Customers and Long-Lived Assets [Line Items] Subsequent Event Subsequent Event [Member] Schedule of Weighted-Average Assumptions to Measure the Fair Value of Stock Options Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Selling, general, and administrative Selling, General and Administrative Expenses [Member] Cost of sales Cost of Sales [Member] Equity securities Equity Securities, FV-NI Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Depreciation expense Depreciation Unvested at the end of the period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Money market funds Money Market Funds [Member] Amortized Cost Debt Securities, Available-for-Sale, Amortized Cost, Rolling Maturity [Abstract] Equity Components [Axis] Equity Components [Axis] ROW Non-US [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Organization and Business Description Nature of Operations [Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Concentration Risk [Table] Concentration Risk [Table] Total Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value Supplemental cash flow information: Supplemental Cash Flow Information [Abstract] Other Performance Measure, Amount Other Performance Measure, Amount U.S. government and agency securities US Treasury and Government [Member] Entity Address, State or Province Entity Address, State or Province Net product sales, cost of product sales and gross profit by product Net Product Sales, Cost Of Product Sales, And Gross Profit By Product [Line Items] No definition available. Total current liabilities Liabilities, Current Individual: Individual [Axis] Earnings Per Share Reconciliation [Abstract] Earnings Per Share Reconciliation [Abstract] Other current assets Other Assets, Current Research and development Research and Development Expense [Member] Additional paid-in capital Additional Paid in Capital, Common Stock Investments [Abstract] Investments [Abstract] Entity [Domain] Entity [Domain] Decrease in value of investment, cumulative amount Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount Net cash provided by (used in) investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activity Document Fiscal Year Focus Document Fiscal Year Focus STAP awards Share Tracking Awards Plan [Member] Share tracking award plans (STAP) is a long-term, equity-based compensation plan for eligible participants. Awards granted under this plan are non-dilutive as they are not settled in shares of entity's common stock and convey the right to receive in cash an amount equal to the appreciation of entity's common stock. Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Repayments of long term debt Repayments of Long-Term Debt Effective income tax rate (as a percent) Effective Income Tax Rate Reconciliation, Percent Entity Interactive Data Current Entity Interactive Data Current Plan Name [Domain] Plan Name [Domain] Smiths Medical ASD, Inc. Smiths Medical ASD, Inc. [Member] Smiths Medical ASD, Inc. Weighted average remaining vesting period (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Total grant date fair value Share Based Compensation Arrangement By Share Based Payment Award Option Grants In Period, Total Grant Date Fair Value Represents the total grant date fair value of option granted during the reporting period. Litigation Legal Matters and Contingencies [Text Block] Term of maturity date extension Debt Instrument, Extension Term Debt Instrument, Extension Term Exercise of stock options (in shares) Exercised (in shares) Number of options exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Exercisable at the end of the period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Second Unsecured Revolving Credit Facility Credit Agreement2022 Second Unsecured Revolving Credit Facility [Member] Credit Agreement2022 Second Unsecured Revolving Credit Facility Increase in value of investment, cumulative amount Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount Total Tyvaso Tyvaso [Member] Represents Tyvaso, a commercial product of the entity, for treating pulmonary arterial hypertension (PAH). Segment Information Segment Reporting Disclosure [Text Block] Orenitram Orenitram [Member] Represents Orenitram, a commercial product of the entity, for treating pulmonary arterial hypertension (PAH). Assets and liabilities subject to fair value measurements Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Newly-Hired Employees Newly Hired Employees [Member] This member represents newly-hired employees. Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Gross Unrealized Losses Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract] Number of shares of common stock entitled to recipient upon vesting (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number Of Shares Entitled To Receive For Each Unit Upon Vesting The number of shares of common stock entitled to receive for each unit upon vesting. Marketable investments Marketable Securities, Noncurrent Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Net income per common share: Net Income Per Common Share [Abstract] Net Income Per Common Share Selling, general, and administrative Selling, General and Administrative Expense Deferred tax assets, net Deferred Income Tax Assets, Net Excise tax on net share repurchase Noncash Excise Tax On Net Share Repurchases Noncash Excise Tax On Net Share Repurchases Depreciation and amortization Depreciation, Depletion and Amortization Other non-current assets Other Assets, Noncurrent Customer [Domain] Customer [Domain] Entity Central Index Key Entity Central Index Key PEO Name PEO Name Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] 2025 Accelerated Share Repurchase Agreement - Collared Agreement 2025 Accelerated Share Repurchase Agreement - Collared Agreement [Member] 2025 Accelerated Share Repurchase Agreement - Collared Agreement Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Land and land improvements Land and Land Improvements [Member] Comprehensive income: Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Current marketable investments Marketable Securities Current [Member] Total debt and equity financial instruments including: (1) securities held-to-maturity and (2) securities available-for-sale that will be held for the short-term. Arrangement Duration Trading Arrangement Duration Loss related to commercial supply agreement Inventory, Firm Purchase Commitment, Loss Work-in-progress Inventory, Work in Process, Net of Reserves Exercise Price Award Exercise Price Entity Filer Category Entity Filer Category Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Subsequent Event Type [Axis] Subsequent Event Type [Axis] Share-Based Compensation Share-Based Payment Arrangement [Text Block] Assets Assets [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Balance Sheet Location [Axis] Statement of Financial Position Location, Balance [Axis] Debt Instrument [Axis] Debt Instrument [Axis] Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Fair Value Measurements Fair Value Disclosures [Text Block] Adcirca Adcirca [Member] Represents Adcirca, a commercial product of the entity, for treating pulmonary hypertension. Time deposits Bank Time Deposits [Member] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Entity Address, Address Line One Entity Address, Address Line One Share repurchase Treasury Stock, Value, Acquired, Cost Method Distributor 2 Distributor Two [Member] Distributor Two Research and development Research and Development Expense Accumulated Other Comprehensive (Loss) Income AOCI Attributable to Parent [Member] Accounts receivable, allowance Accounts Receivable, Allowance for Credit Loss, Current Fair Value as of Grant Date Award Grant Date Fair Value Property, Plant and Equipment [Abstract] Entity Registrant Name Entity Registrant Name Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Sandoz Inc. Sandoz Inc. [Member] Sandoz Inc. Stock options, RSUs, and ESPP (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Relationship to Entity [Domain] Title and Position [Domain] Total operating expenses Costs and Expenses Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Document Quarterly Report Document Quarterly Report Less than 12 months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months Total assets Assets, Fair Value Disclosure Debt Securities, available-for-sale, unrealized loss position, number of positions Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Investments in privately-held companies Equity Securities without Readily Determinable Fair Value, Amount Number of operating segments Number of Operating Segments Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Number of petitions Number Of Petitions Number of petitions. Outstanding at the end of the period (in Years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Liquidia Technologies, Inc. Liquidia Technologies Inc. [Member] Represents information pertaining to Liquidia Technologies, Inc. Tax (benefit) expense in other comprehensive income for available-for-sale debt securities Other Comprehensive Income (Loss), Available-for-Sale Securities, Tax, Portion Attributable to Parent Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Restatement Determination Date: Restatement Determination Date [Axis] Non-PEO NEO Non-PEO NEO [Member] Outstanding at the end of the period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Shares issued under employee stock purchase plan (ESPP) Stock Issued During Period, Value, Employee Stock Purchase Plan Gross Unrealized Gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Name Trading Arrangement, Individual Name Equity Award [Domain] Award Type [Domain] Equity Awards Adjustments Equity Awards Adjustments [Member] Other Other Noncash Income (Expense) Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Compensation Amount Outstanding Recovery Compensation Amount Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Schedule of Net Product Sales, Cost of Product Sales and Gross Profit for Each Commercial Products Schedule Of Net Revenue, Cost Of Product Sales And Gross Profit By Product [Table Text Block] Tabular disclosure of revenues, cost of revenues and gross profit for each commercial product during the period. Executives Executives [Member] Executives Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Balance Estimate of Fair Value Measurement [Member] Share Repurchase Program [Axis] Share Repurchase Program [Axis] Aggregate Intrinsic Value (in millions) Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value Disclosures [Abstract] Investments in Privately-Held Companies and Investments in Equity Securities with Readily Determinable Fair Values Schedule of Investments [Line Items] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Unvested at beginning of the period (in dollars per share) Unvested at the end of the period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Contingent consideration Business Acquisition, Contingent Consideration, Fair Value Disclosure, Liability Fair value, as of the balance sheet date, of potential payments under the contingent consideration arrangement including cash and shares. Increase in fair value of contingent consideration liability Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] ESPP Employee Stock [Member] Maximum number of shares each eligible employees may purchase in any given offering period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Number of Shares Per Employee Fair Value Debt Securities, Available-for-Sale, Maturity, Fair Value, Rolling Maturity [Abstract] Share-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Accumulated other comprehensive (loss) income Accumulated Other Comprehensive Income (Loss), Net of Tax Financial Instruments [Domain] Financial Instruments [Domain] Litigation Case [Axis] Litigation Case [Axis] Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Line of credit Line of Credit, Current Balance Sheet Location [Domain] Statement of Financial Position Location, Balance [Domain] Inventories Increase (Decrease) in Inventories Inventories, net Total inventories Inventory, Net Less—accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Company Selected Measure Name Company Selected Measure Name Fair Value Measurement [Domain] Fair Value Measurement [Domain] Purchases of available-for-sale debt securities Payments to Acquire Debt Securities, Available-for-Sale Debt Debt Disclosure [Text Block] Preferred stock, par value $.01, 10,000,000 shares authorized, no shares issued Preferred Stock, Value, Issued Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] First Unsecured Revolving Credit Facility Credit Agreement2022 First Unsecured Revolving Credit Facility [Member] Credit Agreement2022 First Unsecured Revolving Credit Facility All Executive Categories All Executive Categories [Member] Stockholders' Equity Note [Abstract] Finished goods Inventory, Finished Goods, Net of Reserves Common stock, par value $.01, 245,000,000 shares authorized, 77,129,770 and 76,452,253 shares issued, and 42,156,223 and 43,643,165 shares outstanding as of March 31, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Title of Individual [Axis] Title and Position [Axis] Diluted (in shares) Weighted average shares - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Commitments and contingencies Commitments and Contingencies Total grant date fair value of employee stock options that vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Increase in borrowing capacity Line Of Credit Facility, Contingent Increase, Additional Borrowing Capacity The contingent increase above the maximum borrowing capacity under the credit facility, if any one or more of the existing banks or new banks agree to provide such increased commitment amount. Entity Small Business Entity Small Business Schedule of Net Revenues from External Customers by Geographic Area Revenue from External Customers by Geographic Areas [Table Text Block] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Document Transition Report Document Transition Report Schedule of Concentration of Risk Disclosure Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Numerator: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Underlying Securities Award Underlying Securities Amount Segment Information Concentration Risk [Line Items] Tax (benefit) expense in other comprehensive income for the defined benefit pension plan Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax, Attributable to Parent Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Income Taxes Income Tax Disclosure [Text Block] 2026 Accelerated Share Repurchase Agreement - Collared Agreement 2026 Accelerated Share Repurchase Agreement - Collared Agreement [Member] 2026 Accelerated Share Repurchase Agreement - Collared Agreement Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Schedule of Investments [Table] Schedule of Investments [Table] 2025 Share Repurchase Program 2025 Share Repurchase Program [Member] 2025 Share Repurchase Program Exercisable at the end of the period (in Years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Document Type Document Type Level 3 Fair Value, Inputs, Level 3 [Member] Name Outstanding Recovery, Individual Name Loss Contingencies [Table] Loss Contingencies [Table] Product and Service [Axis] Product and Service [Axis] Revenue from Contract with Customer Benchmark Revenue from Contract with Customer Benchmark [Member] Total revenues Total revenues Revenue from Contract with Customer, Excluding Assessed Tax Stock repurchase program, percentage of shares to be repurchased Stock Repurchase Program, Percentage Of Shares To Be Repurchased Stock Repurchase Program, Percentage Of Shares To Be Repurchased All Individuals All Individuals [Member] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Purchases of property, plant, and equipment Payments to Acquire Property, Plant, and Equipment Unvested at the end of the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Name Forgone Recovery, Individual Name Buildings, building improvements, and leasehold improvements Buildings Building Improvements And Leasehold Improvements [Member] Details pertaining to buildings, building improvements and leasehold improvements. Total current assets Assets, Current Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Litigation settlement interest Litigation Settlement Interest Loss contingency accrual Loss Contingency Accrual Share repurchase program, authorized amount Share Repurchase Program, Authorized, Amount Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Share based compensation arrangement by share based payment award, purchase price of common stock, percent Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Total intrinsic value of options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value RSUs withheld for taxes Payment, Tax Withholding, Share-Based Payment Arrangement Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Marketable investments Marketable Securities, Current Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Share Repurchase Program [Domain] Share Repurchase Program [Domain] Fair Value Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value [Abstract] Debt Securities, Available-For-Sale, Unrealized Loss Position, Fair Value Other comprehensive (loss) income, net of tax Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Current liabilities: Liabilities, Current [Abstract] Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Geographical [Axis] Geographical [Axis] Unrealized (loss) gain arising during period, net of tax OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax Other assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Total defined benefit pension plan, net of tax Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent Level 1 Fair Value, Inputs, Level 1 [Member] Tyvaso DPI Tyvaso DPI [Member] Tyvaso DPI Share-based compensation expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Diluted (in dollars per share) Earnings Per Share, Diluted Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Accounts receivable, no allowance for 2026 and 2025 Accounts Receivable, after Allowance for Credit Loss, Current Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Security 12b Title Title of 12(b) Security Unvested at the end of the period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Non-cash investing and financing activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Due within one year Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost Share repurchase program, excise tax, payable Share Repurchase Program, Excise Tax, Payable Other comprehensive income: Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Privately-held Companies Privately Held Companies [Member] Information pertaining to privately-held companies. Treasury stock (in shares) Treasury Stock, Common, Shares 2026 Accelerated Share Repurchase Agreement - Uncollared Agreement 2026 Accelerated Share Repurchase Agreement - Uncollared Agreement [Member] 2026 Accelerated Share Repurchase Agreement - Uncollared Agreement Net income per common share: Earnings Per Share [Abstract] Total other (expense) income, net Nonoperating Income (Expense) Gross profit (loss) Gross Profit Awards granted in period, fair value Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Granted In Period, Fair Value Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Granted In Period, Fair Value Unrecognized tax benefits, including interest Unrecognized Tax Benefits, Including Interest Unrecognized Tax Benefits, Including Interest 2025 Accelerated Share Repurchase Agreement - Uncollared Agreement 2025 Accelerated Share Repurchase Agreement - Uncollared Agreement [Member] 2025 Accelerated Share Repurchase Agreement - Uncollared Agreement 2026 Accelerated Share Repurchase Agreements 2026 Accelerated Share Repurchase Agreements [Member] 2026 Accelerated Share Repurchase Agreements Effect of dilutive securities: Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract] Stock repurchased during period, shares (in shares) Treasury Stock, Shares, Acquired Cash paid for income taxes Income Taxes Paid, Net Summary of stock option exercise data Share-Based Payment Arrangement, Disclosure [Abstract] Number of accelerated share repurchase agreements Share Repurchase Program, Number Of Accelerated Repurchase Agreements Share Repurchase Program, Number Of Accelerated Repurchase Agreements Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Award Timing Disclosures [Line Items] Weighted Average Remaining Contractual Term (in Years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term Disclosures [Abstract] N/A. Schedule of Inventories, Net of Reserves Schedule of Inventory, Current [Table Text Block] Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Property, Plant, and Equipment Property, Plant and Equipment Disclosure [Text Block] Payments for legal settlements Payments for Legal Settlements Stockholders’ Equity Equity [Text Block] Net income Net income Net Income (Loss) Attributable to Parent Schedule of Available-for-Sale Debt Securities in an Unrealized Loss Position Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] Expiration Date Trading Arrangement Expiration Date Purchase of investment in privately held company Payments To Acquire Equity Securities Without Readily Determinable Fair Value Payments To Acquire Equity Securities Without Readily Determinable Fair Value Buildings under construction Construction in Progress [Member] Net unrealized losses on equity securities Equity Securities, FV-NI, Unrealized Gain (Loss) Total (loss) gain on available-for-sale debt securities, net of tax Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Property, plant, and equipment, net Property, plant, and equipment, net Property, Plant and Equipment, Net Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Payments to repurchase common stock Payments to repurchase common stock Payments for Repurchase of Common Stock Adoption Date Trading Arrangement Adoption Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Accounts receivable Increase (Decrease) in Accounts Receivable Proceeds from the issuance of stock under ESPP Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised Entity Current Reporting Status Entity Current Reporting Status Customer [Axis] Customer [Axis] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Operating income Operating Income (Loss) Retained earnings Retained Earnings (Accumulated Deficit) 2015 Plan Stock Incentive Plan 2015 Plan [Member] Information relating to 2015 Stock Incentive Plan (the 2015 Plan). Schedule of Components of Share-Based Compensation Expense Recognized Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Debt instrument, additional extension term Debt Instrument, Additional Extension Term Debt Instrument, Additional Extension Term Financial Instrument [Axis] Financial Instrument [Axis] Adjustments to reconcile net income to net cash provided by operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item [Abstract] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures 12 months or longer Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Proceeds from issuance of long-term debt Proceeds from Issuance of Long-Term Debt Current Fiscal Year End Date Current Fiscal Year End Date RSUs with Performance Conditions Restricted Stock Units (RSUs) With Performance Conditions [Member] Restricted Stock Units (RSUs) With Performance Conditions Expected term of awards (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Subsequent Event Type [Domain] Subsequent Event Type [Domain] Less than 12 months Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Maximum number of shares authorized to be issued (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Statement [Table] Statement [Table] Other expense, net Other Nonoperating Income (Expense) Maximum percentage of compensation employees may contribute for ESPP (in percentage) Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate Deferred income taxes Deferred Income Tax Expense (Benefit) Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Weighted average grant date fair value of stock options (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Total Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss Schedule of Assets and Liabilities Subject to Fair Value Measurements Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Investments in equity securities with readily determinable fair value Equity Securities, FV-NI, Current 2025 Accelerated Share Repurchase Agreements 2025 Accelerated Share Repurchase Agreements [Member] 2025 Accelerated Share Repurchase Agreements Stock options and RSUs excluded from calculation (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Weighted average number of common shares outstanding: Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] All Adjustments to Compensation All Adjustments to Compensation [Member] Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current Amendment Flag Amendment Flag Related income tax benefit Share-Based Payment Arrangement, Expense, Tax Benefit Maximum number of shares authorized to be issued (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Treasury stock, 34,973,547 and 32,809,088 shares as of March 31, 2026 and December 31, 2025, respectively Treasury Stock, Common, Value Termination Date Trading Arrangement Termination Date Due in one to three years Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Rolling Year One Through Three, Amortized Cost Basis Amount after adjustments of available-for-sale debt securities at cost, maturing in the third rolling twelve months following the latest balance sheet. Adjustments include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings less cumulative-effect adjustments, and fair value hedge accounting adjustments. For interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date Net cash used in financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Raw materials Inventory, Raw Materials, Net of Reserves Schedule of Activity and Status of Stock Options Share-Based Payment Arrangement, Option, Activity [Table Text Block] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Basic (in shares) Weighted average outstanding shares - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Inventory reserve Inventory Write-down Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Cost of sales Cost of Product and Service Sold Schedule of Components of Basic and Diluted Earnings (Loss) Per Common Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Exercisable at the end of the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Segment Reporting [Abstract] Segment Reporting [Abstract] Available-for-sale debt securities: OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax [Abstract] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Entity Tax Identification Number Entity Tax Identification Number 2025 Credit Agreement 2025 Credit Agreement [Member] 2025 Credit Agreement Operating expenses: Costs and Expenses [Abstract] Number of equity incentive plans Number Of Equity Incentive Plans Number of shareholder-approved equity incentive plans. Outstanding at beginning of the period (in dollars per share) Outstanding at the end of the period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-Based Compensation Awards granted Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares issued (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Issued Actuarial gain and prior service cost included in net periodic pension cost, net of tax Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax Litigation settlement, amount awarded to other party Litigation Settlement, Amount Awarded to Other Party Interest expense Interest Expense, Nonoperating Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Litigation Loss Contingencies [Line Items] Increase in value of investment, annual amount Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount Insider Trading Arrangements [Line Items] Non-current marketable investments Marketable Securities Noncurrent [Member] Total debt and equity financial instruments including: (1) securities held-to-maturity and (2) securities available-for-sale that will be held for the long-term. Security Exchange Name Security Exchange Name Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Other Product and Service, Other [Member] Total liabilities Liabilities Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Other income (expense), net Other Nonoperating Income (Expense) [Member] Total Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost Non-cash additions to property, plant, and equipment Capital Expenditures Incurred but Not yet Paid Borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Current available-for-sale debt securities Debt Securities, Available-for-Sale, Excluding Accrued Interest, Current Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Other current liabilities Other Liabilities, Current Statement Statement [Line Items] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalent Additional number of shares authorized to be issued (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Common Stock Common Stock [Member] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Debt securities, available-for-sale Debt Securities, Available-for-Sale Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Corporate debt securities Corporate Debt Securities [Member] Net (decrease) increase in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation